Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Urinary Incontinence 1Rectal Neoplasms 1Prostatic Neoplasms 1Fecal Incontinence 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Biofeedback, Psychology × Clear all
NCT00515853 2022-03-07

The Role of Biofeedback in Improving Continence After Anterior Resection

University of Southampton

Phase NA Completed
121 enrolled 9 charts
Gastrointestinal

Fecal Incontinence, Rectal Neoplasms

NCT00212264 2016-04-11

Conservative Treatment of Postprostatectomy Incontinence

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase NA Completed
208 enrolled 9 charts
Genitourinary

Prostatic Neoplasms, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡